Oxcia Ab Publ
Oxcia AB is a pioneer in oxidative DNA damage and DNA Damage Response (DDR – the body’s way of repairing the damage that occurs to DNA). The two most advanced projects emanating from the O2-DDR technology platform are OXC-101 for cancer and OXC-201 for pulmonary fibrosis. The portfolio also includes exploratory projects, e.g. in psoriasis and non-disclosed discovery projects.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
12
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
0
tools in use
Monthly traffic
4
organic / mo
Sign up free to see all 5 verified contacts at Oxcia Ab Publ
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- CK
Christina Kalderén
Preclinical Director · Science
EmailPhone - MV
Monika Vedin
Strategy & Communications Director · Advertising & Marketing
EmailPhone - SE
Sandra Ekstedt
Senior Scientist · Science
EmailPhone - AS
Austin Smith
Oxcia Ab (Publ) · Other
EmailPhone - IK
Ingvar Karlsson
Board Member · General Business & Management
EmailPhone
Showing 5 of 5 verified contacts
Top roles at Oxcia Ab Publ
5 distinct titles indexed · top 5 shown.
- 1board member
- 1oxcia ab (publ)
- 1preclinical director
- 1senior scientist
- 1strategy & communications director
Sign up to unlock all 5 contacts at Oxcia Ab Publ
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Oxcia Ab Publ
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.